Pamidronate in Cats

Pamidronate is an injectable bisphosphonate that your vet may use in cats when calcium levels are dangerously high or when a bone-invasive cancer is causing pain and bone breakdown. In feline medicine, it is usually given as an intravenous infusion in the hospital rather than as a take-home medication. The most common reason it is used is hypercalcemia, which can happen with some cancers, vitamin D toxicosis, primary hyperparathyroidism, or idiopathic hypercalcemia. It may also be considered as part of palliative care for cats with tumors that damage bone.

This medication does not cure the underlying disease. Instead, it helps control one important consequence of that disease: excess bone resorption and calcium release. That can make a cat feel better, protect organs from ongoing high calcium exposure, and buy time while your vet works on diagnosis and a broader treatment plan. Because pamidronate can affect the kidneys and mineral balance, cats receiving it usually need bloodwork before treatment and follow-up monitoring afterward.

Pamidronate is used off-label in cats, which is common in veterinary medicine. Off-label means the drug is being used based on veterinary evidence and clinical experience rather than a cat-specific FDA label. Your vet will decide whether it fits your cat’s situation based on the cause of the high calcium, kidney values, hydration status, and overall goals of care.

Pamidronate works by slowing osteoclasts, the cells that break down bone. When bone is resorbed too quickly, calcium is released into the bloodstream. By reducing osteoclast activity, pamidronate decreases bone resorption and helps lower calcium levels over time. This is why it is grouped with other bisphosphonates such as alendronate and zoledronate.

In cats with hypercalcemia, the effect is not always immediate. IV fluids and treatment of the underlying cause are often started first, and pamidronate is added when your vet needs a stronger way to reduce calcium release from bone. In oncology cases, the same anti-resorptive effect may also help reduce pain from osteolysis, meaning painful destruction of bone around a tumor.

Some veterinary oncology literature also suggests pamidronate may have direct anti-tumor effects in certain settings, but its main practical role in cats is still supportive care rather than primary cancer treatment. Most cats receive it as part of a larger plan that may include fluids, diet changes, steroids in selected cases, cancer treatment, or other medications depending on the diagnosis.

The main concern with pamidronate in cats is kidney stress. Because the drug is cleared through the kidneys and other bisphosphonates in this class can be nephrotoxic, your vet will usually check kidney values and hydration status before treatment. Cats that already have kidney disease are not automatically excluded, but they often need more careful planning, slower infusion protocols, and closer recheck testing.

Other possible side effects include low calcium after treatment, low phosphorus, decreased appetite, vomiting, lethargy, or weakness. If calcium drops too far, signs can include muscle twitching, tremors, facial rubbing, restlessness, or seizures, though severe hypocalcemia appears uncommon. Cats being treated for vitamin D toxicosis or severe hypercalcemia often need serial bloodwork because their calcium can shift over several days.

Infusion-related irritation is also possible if the drug leaks outside the vein, so careful IV catheter placement matters. In practice, many cats tolerate pamidronate well when it is diluted and given slowly, but monitoring is a key part of safe use. Contact your vet promptly if your cat seems more weak, stops eating, vomits repeatedly, or seems painful after treatment.

Pamidronate is usually given by IV infusion in a veterinary hospital. Published veterinary references commonly list doses around 1 to 2 mg/kg IV, with many feline protocols using about 1.3 mg/kg infused over roughly 2 hours. The exact dose, dilution, and infusion time vary by the reason for treatment, your cat’s kidney values, and whether the goal is emergency calcium control or ongoing palliative support.

This is not a medication pet parents should give at home. Your vet will typically place an IV catheter, dilute the drug in fluids, and monitor your cat during the infusion. Blood calcium, kidney values, phosphorus, and hydration status are often checked before treatment and then rechecked afterward. In some cats, one dose is enough for a short-term crisis. Others may need repeat treatment every 3 to 4 weeks if the underlying problem persists.

Because response time can vary, pamidronate is often paired with other supportive measures at the start, especially IV fluids. If your cat is being treated for idiopathic hypercalcemia, your vet may also discuss oral bisphosphonates such as alendronate for longer-term management. The right plan depends on the diagnosis, how high the calcium is, and how your cat is feeling overall.

Pamidronate is most often used alongside other hospital treatments, but combination plans need thought. Drugs or situations that can stress the kidneys deserve extra caution. That includes dehydration, pre-existing kidney disease, and other potentially nephrotoxic medications. Your vet may adjust fluid therapy, infusion timing, or monitoring if your cat is also receiving chemotherapy, NSAIDs, or other medications that affect renal perfusion.

Mineral balance also matters. Because pamidronate lowers calcium by reducing bone resorption, combining it with other calcium-lowering strategies can increase the risk of overcorrection. Depending on the case, your vet may use fluids, glucocorticoids, diet changes, phosphate binders, or loop diuretics, but the sequence and timing matter. In vitamin D toxicosis, for example, treatment plans are often layered and then adjusted based on serial calcium and phosphorus results.

Tell your vet about every medication, supplement, and toxin exposure your cat may have had, including vitamin D products, rodenticides, calcium supplements, and prescription diets. That history helps your vet choose the safest combination plan and decide how aggressively to monitor after pamidronate is given.